La cadena de opciones muestra datos clave de las opciones de acciones de Loop Industries a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Loop Industries..

Loop Industries (NASDAQ:LOOP) Bolsa, Cadena de Opciones

Loop Industries

Loop Industries Inc is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers). Its monomers are filtered, purified and repolymerized to create virgin-quality Loop branded PET plastic resin and polyester fiber suitable for use in food-grade packaging to be sold to consumer goods companies to help them meet their sustainability objectives.

Loop Industries Inc

Loop Energy Inc

Loop Media Inc

LoopUp Group PLC

Loopring - United States Dollar

Earnings

News

SBC Medical Group Holding Q1 EPS $0.21 Up From $0.20 YoY, Sales $47.33M Down From $54.81M YoY

Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) reported quarterly losses of $(0.02) per share. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported $3.57 million in sales this quarter. This is a 8.20 percent decrease over sales of $3.89 million the same period last year.

MITQ

Moving iMage Technologies Q3 EPS $(0.02) Up From $(0.06) YoY, Sales $3.57M Down From $3.89M YoY

Needham analyst Mike Cikos reiterates CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) with a Buy and maintains $55 price target.

Price Target

Reiteration

Analyst Ratings

CRWV

Needham Reiterates Buy on CoreWeave, Maintains $55 Price Target

Rosenblatt analyst Barton Crockett maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and raises the price target from $15 to $16.

NEXN

Rosenblatt Maintains Buy on Nexxen International, Raises Price Target to $16

PENN

PENN Entertainment Sends Letter to Shareholders; Says PENN Play Loyalty Member Base Has Grown 10% YoY And Says Expects To Accelerate Return Of Capital To Shareholders In The Second Half Of The Year And Repurchase At Least $350M Of Common Stock In Calendar 2025

WIIM

Foot Locker shares are trading higher after DICK's Sporting Goods agreed to acquire the company. Also, the company issued preliminary Q1 Non-GAAP EPS results.

Earnings Beats

ABEO

Abeona Therapeutics Q1 EPS $(0.24) Beats $(0.36) Estimate

Rosenblatt analyst Mike Genovese maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Buy and raises the price target from $63 to $74.

CSCO

Rosenblatt Maintains Buy on Cisco Systems, Raises Price Target to $74

HC Wainwright &amp; Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) with a Buy and raises the price target from $51 to $53.

SMTI

HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $53

N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland
Neve Yarak, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) (FSE:80W) ("N2OFF" and the "Company"), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, recently announced its entry into the Polish renewable energy market by participating in the financing of a Battery Energy Storage System (BESS) project in Poland.
The project, currently planned at 35MW/140MWh, represents a significant step in expanding Solterra's large-scale energy storage solutions in the region. N2OFF, along with other lenders, will assist with financing an initial payment under a signed grid connection agreement. Future development plans include applying for an increase in capacity to more than 100MW/400MWh.

NITO

N2OFF Enters Into Polish Renewable Energy Market By Participating In Financing Of Battery Energy Storage System Project In Poland

BHVN

Biohaven shares are trading lower after the FDA's Office of Neuroscience extended the PDUFA date for the troriluzole new drug application for the treatment of spinocerebellar ataxia by three months to provide time for a full review of the company's recent submissions related to information requests from the agency.

Earnings Misses

FTLF

FitLife Brands Q1 EPS $0.20 Misses $0.29 Estimate, Sales $15.94M Beat $15.77M Estimate

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cadrenal.com%2F&amp;esheet=54255465&amp;newsitemid=20250515408603&amp;lan=en-US&amp;anchor=Cadrenal+Therapeutics%2C+Inc.&amp;index=1&amp;md5=eb57e3bf892902967f302bae6cefbdca">Cadrenal Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a novel oral vitamin K antagonist (VKA) anticoagulant that is designed to address unmet needs in anticoagulation therapy.
Cadrenal completed the technical transfer and manufacturing of its tecarfarin drug substance in accordance with current good manufacturing practices (cGMP) earlier this year at a U.S. site of a leading global Contract Development and Manufacturing Organization (CDMO). Manufacturing of the tecarfarin drug product candidate is currently underway.

CVKD

Cadrenal Therapeutics Announces Manufacturing And Supply Chain Milestones For Tecarfarin, Oral VKA Anticoagulant Designed To Address Unmet Needs In Anticoagulation Therapy

Needham analyst Ryan Koontz reiterates Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Buy and maintains $130 price target.

ANET

Needham Reiterates Buy on Arista Networks, Maintains $130 Price Target

NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) reported quarterly losses of $(0.05) per share. This is a 37.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $14.53 million in sales this quarter. This is a 16.97 percent decrease over sales of $17.49 million the same period last year.

NXPL

NextPlat Q1 EPS $(0.05) Up From $(0.08) YoY, Sales $14.53M Down From $17.49M YoY

ELEV

Elevation Oncology Q1 EPS $(0.24) Misses $(0.19) Estimate

Health Care

General

CYBN

Cybin Engages Thermo Fisher To Support Phase 3 Supply And Potential Commercial Manufacturing Of CYB003 In Development For Major Depressive Disorder

Auxly Cannabis Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) reported quarterly earnings of $0.01 per share. This is a 150 percent increase over losses of $(0.02) per share from the same period last year. The company reported $22.76 million in sales this quarter. This is a 21.53 percent increase over sales of $18.73 million the same period last year.

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

Auxly Cannabis Group Q1 GAAP EPS $0.01 Up From $(0.02) YoY, Sales $22.76M Up From $18.73M YoY

EDBL

Edible Garden AG Q1 EPS $(2.47) Beats $(3.03) Estimate, Sales $2.70M Miss $3.82M Estimate

Arthur Hayes, Chief Investment Officer of Maelstrom and co-founder of BitMEX on Thursday said that foreign capital repatriation and the devaluation of U.S. Treasury bonds will be the twin forces driving Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to $1 million within the <a href="https://in.benzinga.com/markets/25/05/45384424/great-progress-made-trump-says-traders-react-as-bitcoin-pops-then-stalls-at-key-resistance">next presidential cycle</a>.
What Happened: His thesis is rooted in structural imbalances in the U.S. trade and capital accounts and the political imperative to resolve them not through austerity, but through capital controls and money printing.
&#8220;Foreign capital repatriation and the devaluation of the gargantuan stock of U.S. treasuries will be the two catalysts that will power Bitcoin to $1 million sometime between now and 2028,&#8221; Hayes <a href="https://cryptohayes.substack.com/p/fatty-fatty-boom-boom">wrote</a>.
The essay dissects the growing tension between the U.S.'s reliance on foreign capital to finance its deficits and the political unwillingness to pursue hardline trade protectionism. 
Hayes argues that tariffs are an insufficient tool for rebalancing trade flows and are politically unsustainable in the short term, especially when they raise consumer prices. 
Instead, he predicts a shift to capital controls, specifically targeting the foreign ownership of U.S. financial assets like stocks, bonds and real estate.
Hayes envisions a 2% annual tax on foreign-owned financial assets, which he believes could generate enough revenue to eliminate income taxes for most U.S. households. 
"Trump could eliminate income taxes for the vast majority of voters by placing a 2% foreign capital tax on stocks, bonds, and property," he wrote.
This tax, he argues, would either discourage foreigners from accumulating U.S. assets, thus weakening the dollar and making U.S. exports more competitive, or allow capital inflows to continue while redistributing tax revenues domestically. 
"Either foreign capital stays, pays the tax, and revenue is used to eliminate income taxes… or foreign capital leaves, and American manufacturing grows," Hayes explained.
But foreign capital fleeing U.S. assets would have systemic implications. 
Hayes points out that the U.S. financial system is deeply reliant on steady demand for Treasury bonds, especially long-duration debt, and warns that a collapse in demand could trigger a surge in yields, destabilizing markets.
To counter this, Hayes predicts the Federal Reserve will resume quantitative easing (QE) and other expansionary measures to absorb the supply of Treasuries as foreign investors exit. 
"Bond prices will rise and yields collapse. The Fed will buy bonds due to its QE policy," he wrote.
In his view, this renewed round of money printing will debase U.S. debt and fiat savings, driving investors toward hard assets. 
Why It Matters: Hayes compares this to how U.S. Treasuries have already lost substantial purchasing power relative to Bitcoin and gold since 2021.
"Treasuries lost 64% and 84% of their value vs. gold and Bitcoin, respectively, from 2021 until the present," he stated, citing indexed ETF performance.
As the monetary system splinters under the weight of these imbalances, Hayes views Bitcoin as the only viable hedge for private capital. 
Unlike gold, which often requires intermediaries and custody solutions susceptible to regulatory interference, Bitcoin is a bearer asset that can be transferred without institutional permission.
&#8220;Bitcoin is the perfect and only lifeboat for global capital that must leave America and elsewhere,&#8221; Hayes declared.
He contends that even if 10% of the $33 trillion in foreign-owned U.S. portfolio assets were to rotate into Bitcoin, the price would not merely rise linearly but potentially explode due to constrained supply and liquidity. 
He envisions a potential "short squeeze of epic proportions" as traditional capital competes to enter the market.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Arthur Hayes Predicts Bitcoin To Hit $1 Million By 2028

Events

Press Releases

Loop Industries to Participate in the 13th Annual ROTH Technology Conference Taking Place November 19-20, 2024

Loop Industries Completes Convertible Preferred Financing With Reed Societe Generale Group and Sells First Technology License For An Infinite Loop Manufacturing Facility in Europe

Power Nickel Extends Lion Zone Depth: See New Mineralized Core Discoveries more stocks inside….

Loop Industries Closes Strategic and Financing Transaction With Reed Societe Generale Group

Loop Industries Reports Third Quarter Fiscal 2025 Results and Provides Update on Business Developments

Contracts

Loop Industries, Hyosung TNC And Pleatsmama Collaborate To Pioneer Circular Fashion With Infinite Loop(TM) Textile-to-Textile Recycling Technology

Management

Loop Announces Senior Leadership Appointments and Changes

Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025

Loop Industries to Participate in Gabelli Funds' 11th Annual Waste & Sustainability Symposium

ADUR

BLGO

CECO

CFTN

CWST

GAMI

LOOP

PACK

PESI

PNPNF

SCWO

TOPP

TSX:BTO

TSX:EDR

TSX:IMG

TSX:SES

TSXV:PNPN

AdvanSix

Braskem

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

CN Energy Group Inc. - Class A Ordinary Shares

CN Energy Group

Gulf Resources

Hawkins

Koppers Holdings

Kronos Worldwide

Mativ Holdings

Orion

Olin

Origin Materials, Inc. - Class A Common Stock

Origin Materials

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical

Comments

Loop Industries

Loop Industries (LOOP) Opciones

Loop Industries (NASDAQ:LOOP) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL